{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:16:07Z","timestamp":1753892167620,"version":"3.41.2"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2023.1037610","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T05:48:50Z","timestamp":1673848130000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Editorial: Pathophysiological and clinical advances in asthmatic inflammation from the nasopharynx to the peripheral airway in the respiratory tract systems"],"prefix":"10.3389","volume":"14","author":[{"given":"Yasuhiko","family":"Koga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Kamide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Hisada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamotsu","family":"Ishizuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/29547","article-title":"The stomach is a source of leptin","volume":"394","author":"Bado","year":"1998","journal-title":"Nature"},{"key":"B2","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1185\/03007995.2013.877435","article-title":"Evaluation of two commercial omalizumab\/free IgE immunoassays: Implications of use during therapy","volume":"30","author":"Baker","year":"2014","journal-title":"Curr. Med. Res. Opin."},{"key":"B3","doi-asserted-by":"publisher","first-page":"519","DOI":"10.18176\/jiaci.0689","article-title":"Benralizumab: Resolution of eosinophilic pulmonary vasculitis in a patient with EGPA","volume":"31","author":"Bormioli","year":"2021","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.alit.2020.03.001","article-title":"Early benralizumab for eosinophilic myocarditis in eosinophilic granulomatosis with polyangiitis","volume":"69","author":"Colantuono","year":"2020","journal-title":"Allergol. Int."},{"key":"B5","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.jaip.2021.09.021","article-title":"Higher risk of hyperthyroidism in people with asthma: Evidence from a nationwide, population-based cohort study","volume":"10","author":"Gau","year":"2022","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1111\/jcmm.16269","article-title":"Metformin alleviates allergic airway inflammation and increases Treg cells in obese asthma","volume":"25","author":"Guo","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"B7","first-page":"586","article-title":"Research progress of non-coding RNA in regulating the function of T cells in asthma","volume":"72","author":"Huang","year":"2020","journal-title":"Sheng Li Xue Bao"},{"key":"B8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2332\/allergolint.13-OA-0643","article-title":"Development of assay for determining free IgE levels in serum from patients treated with omalizumab","volume":"63","author":"Ito","year":"2014","journal-title":"Allergol. Int."},{"key":"B9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s11010-009-0286-z","article-title":"MUC5AC production is downregulated in NCI-H292 lung cancer cells cultured on type-IV collagen","volume":"337","author":"Iwashita","year":"2010","journal-title":"Mol. Cell Biochem."},{"key":"B10","doi-asserted-by":"publisher","first-page":"0613","DOI":"10.2169\/internalmedicine.0613-22","article-title":"Long-term safety and efficacy of benralizumab for eosinophilic granulomatosis with polyangiitis complicated with severe neuropathy","author":"Koga","year":"2022","journal-title":"Intern Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1002\/ppul.23331","article-title":"MicroRNA expression profiling in children with different asthma phenotypes","volume":"51","author":"Midyat","year":"2016","journal-title":"Pediatr. Pulmonol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"00451","DOI":"10.1183\/23120541.00451-2020","article-title":"Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis","volume":"6","author":"Nanzer","year":"2020","journal-title":"ERJ Open Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3390\/genes8120348","article-title":"Non-coding RNAs in pediatric airway diseases","volume":"8","author":"Narozna","year":"2017","journal-title":"Genes (Basel)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.1016\/j.jaip.2020.05.033","article-title":"Benralizumab as a glucocorticoid-sparing treatment option for severe asthma in eosinophilic granulomatosis with polyangiitis","volume":"8","author":"Padoan","year":"2020","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"B15","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/cphy.c130013","article-title":"Air quality and temperature effects on exercise-induced bronchoconstriction","volume":"5","author":"Rundell","year":"2015","journal-title":"Compr. Physiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"196","DOI":"10.2174\/1871530315666150316124019","article-title":"Metformin and inflammation: Its potential beyond glucose-lowering effect","volume":"15","author":"Saisho","year":"2015","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.3390\/biomedicines10112874","article-title":"Therapeutical targets in allergic inflammation","volume":"10","author":"Salvati","year":"2022","journal-title":"Biomedicines"},{"key":"B18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00005-019-00547-4","article-title":"MicroRNAs: Potential biomarkers and targets of therapy in allergic diseases?","volume":"67","author":"Specjalski","year":"2019","journal-title":"Arch. Immunol. Ther. Exp. Warsz."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1111\/all.12922","article-title":"Utility of serum periostin and free IgE levels in evaluating responsiveness to omalizumab in patients with severe asthma","volume":"71","author":"Tajiri","year":"2016","journal-title":"Allergy"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13287-016-0456-3","article-title":"The lncRNAs involved in mouse airway allergic inflammation following induced pluripotent stem cell-mesenchymal stem cell treatment","volume":"8","author":"Wang","year":"2017","journal-title":"Stem Cell Res. Ther."},{"key":"B21","doi-asserted-by":"publisher","first-page":"6673525","DOI":"10.1155\/2021\/6673525","article-title":"Metformin and fibrosis: A review of existing evidence and mechanisms","volume":"2021","author":"Wu","year":"2021","journal-title":"J. Diabetes Res."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1037610\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T05:48:53Z","timestamp":1673848133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1037610\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,16]]},"references-count":21,"alternative-id":["10.3389\/fphar.2023.1037610"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1037610","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2023,1,16]]},"article-number":"1037610"}}